taxonomy (8)
protein (102)
source (11)
structure (12)
composition (1)
disease (3)
reference (18)
site (172)
peptide (205)
- Homo sapiens (Human)
- Bos taurus (Bovine)
- Desmodus rotundus (Common vampire bat)
- Mus musculus (House mouse)
- Rattus norvegicus (Norway rat)
- Sus scrofa (Pig)
- Friend murine leukemia virus (F-mulv)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- A disintegrin and metalloproteinase with thrombospondin motifs 12 / Homo sapiens P58397
- Acid ceramidase / Homo sapiens Q13510
- Alpha-2-macroglobulin / Homo sapiens P01023
- Apolipoprotein d / Homo sapiens P05090
- Biglycan / Homo sapiens P21810
- Collagen alpha-1(VI) chain / Homo sapiens P12109
- Collagen alpha-1(XII) chain / Homo sapiens Q99715
- Collagen alpha-2(VI) chain / Homo sapiens P12110
- Decorin / Homo sapiens P07585
- Dystroglycan / Homo sapiens Q14118
- Fibronectin / Homo sapiens P02751
- Haptoglobin / Homo sapiens P00738
- Heterogeneous nuclear ribonucleoprotein A/B isoform 2 / Homo sapiens Q99729-2
- Immunoglobulin heavy constant mu / Homo sapiens P01871
- Integrin alpha-V / Homo sapiens P06756
- Interleukin-1 receptor accessory protein / Homo sapiens Q9NPH3
- Junctional adhesion molecule A / Homo sapiens Q9Y624
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens P11279
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Mannan-binding lectin serine protease 1 / Homo sapiens P48740
- Matrix-remodeling-associated protein 5 / Homo sapiens Q9NR99
- Mucin-5B / Homo sapiens Q9HC84
- Myelin protein P0 / Homo sapiens P25189
- Myelin protein zero-like protein 1 / Homo sapiens O95297
- Periostin / Homo sapiens Q15063
- Phospholipase D3 / Homo sapiens Q8IV08
- Podocalyxin / Homo sapiens O00592
- Polymeric immunoglobulin receptor / Homo sapiens P01833
- Probable serine carboxypeptidase CPVL / Homo sapiens Q9H3G5
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens Q07954
- Recombinant mature angiotensin-converting enzyme 2 - DRAFT DATA / Homo sapiens Q9BYF1
- Rhodopsin / Homo sapiens P08100
- Serpin h1 / Homo sapiens P50454
- Tetraspanin-3 / Homo sapiens O60637
- Thrombospondin-1 / Homo sapiens P07996
- Thrombospondin-2 / Homo sapiens P35442
- Thyroglobulin / Homo sapiens P01266
- Transmembrane protein 106B / Homo sapiens Q9NUM4
- Zinc-alpha-2-glycoprotein / Homo sapiens P25311
- Acetylcholinesterase / Bos taurus P23795
- Salivary plasminogen activator alpha 1 / Desmodus rotundus P98119
- ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 / Mus musculus P56528
- Angiotensin-converting enzyme / Mus musculus P09470
- BDNF/NT-3 growth factors receptor / Mus musculus P15209
- BTB/POZ domain-containing protein 17 / Mus musculus Q9DB72
- Cadherin-10 / Mus musculus P70408
- Cadherin-13 / Mus musculus Q9WTR5
- Carboxypeptidase M / Mus musculus Q80V42
- Cation-dependent mannose-6-phosphate receptor / Mus musculus P24668
- CD166 antigen / Mus musculus Q61490
- Cell adhesion molecule 4 / Mus musculus Q8R464
- Ciliary neurotrophic factor receptor subunit alpha / Mus musculus O88507
- Contactin-3 / Mus musculus Q07409
- Contactin-associated protein-like 2 / Mus musculus Q9CPW0
- Dipeptidyl aminopeptidase-like protein 6 / Mus musculus Q9Z218
- Ephrin-A1 / Mus musculus P52793
- Fibroblast growth factor receptor 1 / Mus musculus P16092
- Hepatocyte cell adhesion molecule / Mus musculus Q640R3
- IgLON family member 5 / Mus musculus Q8HW98
- Immunoglobulin mu chain C region / Mus musculus P01872
- Immunoglobulin superfamily member 8 / Mus musculus Q8R366
- Isoform 14 of Disintegrin and metalloproteinase domain-containing protein 22 / Mus musculus Q9R1V6-16
- Isoform 2D of Voltage-dependent calcium channel subunit alpha-2/delta-1 / Mus musculus O08532-4
- Leucine-rich glioma-inactivated protein 1 / Mus musculus Q9JIA1
- Leukocyte surface antigen CD47 / Mus musculus Q61735
- Low-density lipoprotein receptor-related protein 1B / Mus musculus Q9JI18
- Lysosomal acid phosphatase / Mus musculus P24638
- Lysosome-associated membrane glycoprotein 1 / Mus musculus P11438
- Metabotropic glutamate receptor 3 / Mus musculus Q9QYS2
- Myelin-oligodendrocyte glycoprotein / Mus musculus Q61885
- Nectin-1 / Mus musculus Q9JKF6
- Neural cell adhesion molecule L1 / Mus musculus P11627
- Neurexin-3 / Mus musculus Q6P9K9
- Neurexophilin-1 / Mus musculus Q61200
- Neurexophilin-3 / Mus musculus Q91VX5
- Neurofascin / Mus musculus Q810U3
- Neuronal cell adhesion molecule / Mus musculus Q810U4
- Neuroplastin / Mus musculus P97300
- Noelin / Mus musculus O88998
- Oligodendrocyte-myelin glycoprotein / Mus musculus Q63912
- Plexin-B1 / Mus musculus Q8CJH3
- Plexin-B2 / Mus musculus B2RXS4
- Prolow-density lipoprotein receptor-related protein 1 / Mus musculus Q91ZX7
- Prostaglandin-H2 D-isomerase / Mus musculus O09114
- Receptor-type tyrosine-protein phosphatase F / Mus musculus A2A8L5
- Rho-associated protein kinase 2 / Mus musculus P70336
- Roundabout homolog 2 / Mus musculus Q7TPD3
- Signal-regulatory protein alpha / Mus musculus P97797
- Sortilin-related receptor / Mus musculus O88307
- Synaptophysin-like protein 1 / Mus musculus O09117
- Tenascin-r / Mus musculus Q8BYI9
- Tetraspanin-2 / Mus musculus Q922J6
- Thrombospondin type-1 domain-containing protein 7A / Mus musculus Q69ZU6
- Thy-1 membrane glycoprotein / Mus musculus P01831
- Zinc transporter ZIP10 / Mus musculus Q6P5F6
- Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus P08289
- Major seminal plasma glycoprotein psp-i / Sus scrofa P35495
- Major seminal plasma glycoprotein psp-ii / Sus scrofa P35496
- Knob protein gp70 / Friend murine leukemia virus P03395
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Retina (UBERON_0000966)
- Seminal Fluid (UBERON_0006530)
- BTI-Tn-5B1-4 (CVCL_C190)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
Source
- Free / Lactose / [Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)][Gal(b1-3)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)][Gal(b1-3)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)][Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-3)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Hybrid / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-3)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Hybrid / Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Man(a1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Hybrid / Man(?1-?)[Man(?1-?)]Man(a1-?)[GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
- N-Linked / Hybrid / Man(a1-3)[Man(a1-6)]Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
Reported structure
- Hex:5 HexNAc:3 dHex:1 (avg mass : 1584.4553 )
Composition
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Site-specific analysis of the SARS-CoV-2 glycan shield (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Unreviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Creating a Mass Spectral Reference Library for Oligosaccharides in Human Milk (2018 - Connie A Remoroza, Tytus D Mak, Maria Lorna A De Leoz, Yuri A Mirokhin, Stephen E Stein) / Status : Unreviewed
- Synthesis of Asymmetrical Multiantennary Human Milk Oligosaccharides (2017 - Anthony R Prudden, Lin Liu, Chantelle J Capicciotti, Margreet A Wolfert, Shuo Wang, Zhongwei Gao, Lu Meng, Kelley W Moremen, Geert-Jan Boons) / Status : Unreviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Annotation and Structural Analysis of Sialylated Human Milk Oligosaccharides (2011 - Shuai Wu, Rudolf Grimm, J Bruce German, Carlito B Lebrilla) / Status : Unreviewed
- Development of an Annotated Library of Neutral Human Milk Oligosaccharides (2010 - Shuai Wu, Nannan Tao, J Bruce German, Rudolf Grimm, Carlito B Lebrilla) / Status : Unreviewed
- Hierarchy of post-translational modifications involved in the circulatory longevity of glycoproteins. Demonstration of concerted contributions of glycan sialylation and subunit assembly to the pharmacokinetic behavior of bovine acetylcholinesterase. (2000 - Kronman C, Chitlaru T, Elhanany E, Velan B, Shafferman A) / Status : Reviewed
- Structural characterization of the oligosaccharide chains of native and crystallized boar seminal plasma spermadhesin PSP-I and PSP-II glycoforms. (1999 - Nimtz M, Grabenhorst E, Conradt H, Sanz L, Calvete J) / Status : Reviewed
- Analysis of site-specific N-glycosylation of recombinant Desmodus rotundus salivary plasminogen activator rDSPA alpha 1 expressed in Chinese hamster ovary cells. (1997 - Gohlke M, Nuck R, Kannicht C, Grunow D, Baude G, Donner P, Reutter W) / Status : Reviewed
- Comparative study of the sugar chains of alkaline phosphatases purified from rat liver and rat AH-130 hepatoma cells. Occurrence of fucosylated high-mannose-type and hybrid-type sugar chains. (1996 - Endo T, Fujiwara T, Ikehara Y, Kobata A) / Status : Reviewed
- Structural studies of the N-linked sugar chains of human rhodopsin. (1994 - Fujita S, Endo T, Ju J, Kean E, Kobata A) / Status : Reviewed
- Oligosaccharides at individual glycosylation sites in glycoprotein 71 of Friend murine leukemia virus. (1990 - Geyer R, Dabrowski J, Dabrowski U, Linder D, Schlter M, Schott H, Stirm S) / Status : Reviewed
Reference
- A disintegrin and metalloproteinase with thrombospondin motifs 12 / Homo sapiens
- Acid ceramidase / Homo sapiens
- Alpha-2-macroglobulin / Homo sapiens
- Apolipoprotein d / Homo sapiens
- Biglycan / Homo sapiens
- Collagen alpha-1(VI) chain / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-2(VI) chain / Homo sapiens
- Decorin / Homo sapiens
- Dystroglycan / Homo sapiens
- Fibronectin / Homo sapiens
- Haptoglobin / Homo sapiens
- Heterogeneous nuclear ribonucleoprotein A/B isoform 2 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Integrin alpha-V / Homo sapiens
- Interleukin-1 receptor accessory protein / Homo sapiens
- Junctional adhesion molecule A / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Mannan-binding lectin serine protease 1 / Homo sapiens
- Matrix-remodeling-associated protein 5 / Homo sapiens
- Mucin-5B / Homo sapiens
- Myelin protein P0 / Homo sapiens
- Myelin protein zero-like protein 1 / Homo sapiens
- Periostin / Homo sapiens
- Phospholipase D3 / Homo sapiens
- Podocalyxin / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Probable serine carboxypeptidase CPVL / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Recombinant mature angiotensin-converting enzyme 2 - DRAFT DATA / Homo sapiens
-
Rhodopsin / Homo sapiens
- Undefined site
- Serpin h1 / Homo sapiens
- Tetraspanin-3 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Thrombospondin-2 / Homo sapiens
- Thyroglobulin / Homo sapiens
- Transmembrane protein 106B / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
-
Acetylcholinesterase / Bos taurus
- Undefined site
- Salivary plasminogen activator alpha 1 / Desmodus rotundus
- ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 / Mus musculus
- Angiotensin-converting enzyme / Mus musculus
- BDNF/NT-3 growth factors receptor / Mus musculus
- BTB/POZ domain-containing protein 17 / Mus musculus
- Cadherin-10 / Mus musculus
- Cadherin-13 / Mus musculus
- Carboxypeptidase M / Mus musculus
- Cation-dependent mannose-6-phosphate receptor / Mus musculus
- CD166 antigen / Mus musculus
- Cell adhesion molecule 4 / Mus musculus
- Ciliary neurotrophic factor receptor subunit alpha / Mus musculus
- Contactin-3 / Mus musculus
- Contactin-associated protein-like 2 / Mus musculus
- Dipeptidyl aminopeptidase-like protein 6 / Mus musculus
- Ephrin-A1 / Mus musculus
- Fibroblast growth factor receptor 1 / Mus musculus
- Hepatocyte cell adhesion molecule / Mus musculus
- IgLON family member 5 / Mus musculus
- Immunoglobulin mu chain C region / Mus musculus
- Immunoglobulin superfamily member 8 / Mus musculus
- Isoform 14 of Disintegrin and metalloproteinase domain-containing protein 22 / Mus musculus
- Isoform 2D of Voltage-dependent calcium channel subunit alpha-2/delta-1 / Mus musculus
- Leucine-rich glioma-inactivated protein 1 / Mus musculus
- Leukocyte surface antigen CD47 / Mus musculus
- Low-density lipoprotein receptor-related protein 1B / Mus musculus
- Lysosomal acid phosphatase / Mus musculus
- Lysosome-associated membrane glycoprotein 1 / Mus musculus
- Metabotropic glutamate receptor 3 / Mus musculus
- Myelin-oligodendrocyte glycoprotein / Mus musculus
- Nectin-1 / Mus musculus
- Neural cell adhesion molecule L1 / Mus musculus
- Neurexin-3 / Mus musculus
- Neurexophilin-1 / Mus musculus
- Neurexophilin-3 / Mus musculus
- Neurofascin / Mus musculus
- Neuronal cell adhesion molecule / Mus musculus
- Neuroplastin / Mus musculus
- Noelin / Mus musculus
- Oligodendrocyte-myelin glycoprotein / Mus musculus
- Plexin-B1 / Mus musculus
- Plexin-B2 / Mus musculus
- Prolow-density lipoprotein receptor-related protein 1 / Mus musculus
- Prostaglandin-H2 D-isomerase / Mus musculus
- Receptor-type tyrosine-protein phosphatase F / Mus musculus
- Rho-associated protein kinase 2 / Mus musculus
- Roundabout homolog 2 / Mus musculus
- Signal-regulatory protein alpha / Mus musculus
- Sortilin-related receptor / Mus musculus
- Synaptophysin-like protein 1 / Mus musculus
- Tenascin-r / Mus musculus
- Tetraspanin-2 / Mus musculus
- Thrombospondin type-1 domain-containing protein 7A / Mus musculus
- Thy-1 membrane glycoprotein / Mus musculus
- Zinc transporter ZIP10 / Mus musculus
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
- Major seminal plasma glycoprotein psp-i / Sus scrofa
- Major seminal plasma glycoprotein psp-ii / Sus scrofa
- Knob protein gp70 / Friend murine leukemia virus
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- QCVNLTTR (8aa)
- VLLPLVSSQCVNLTTRTQLPPAYTNSFTR (29aa)
- HIVFWNSSNPK (11aa)
- SPLPAAFTANGTHLQHLAR (19aa)
- SVAQNYSSITHLHSIGK (17aa)
- EIFVANGTQGK (11aa)
- WYSAGLASNSSWFR (14aa)
- YETTNK (6aa)
- LRPLFNK (7aa)
- ISPGKNATGMEVGWYR (16aa)
- NATGMEVGWYR (11aa)
- FSNVTWF (7aa)
- GESPAGAGTGAAAGAGGATAAPPSGNQNGAEGDQINASK (39aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- WKLNK (5aa)
- WQLNGSDIDTSLDHR (15aa)
- QTLFFNGTR (9aa)
- VGVNKNQTVTATFGYPFR (18aa)
- ANTTQPGIVEGGQVIK (16aa)
- VTWFHAIHVSGTNGTKR (17aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- PLQEIQNL (8aa)
- IRNVSDTTK (9aa)
- IRNVSDTTKR (10aa)
- YHGFLNTSYHR (11aa)
- VLTLANFTTK (10aa)
- ADGTVNQIEGEATPVNITEPAKIEVK (26aa)
- DAMVGNYTCEVTELSR (16aa)
- ISNVTPADAGIYYCVK (16aa)
- NVETNNSTVLIEGK (14aa)
- DEGDYFCELQVSGANPMSSNK (21aa)
- NTTYCSK (7aa)
- IIRGWIFGTTLDSKTQSLLIVNNATNVVIK (30aa)
- DGSIVIHNLDYSDNGTFTCDVK (22aa)
- TQSLLIVNNATNVVIKVCEFQFCNDPFL (28aa)
- SLLIVNNATNVVIK (14aa)
- TTLDSKTQSLLIVNNATNVVIK (22aa)
- LIVNNATNVVIK (12aa)
- DSKTQSLLIVNNATNVVIK (19aa)
- LLIVNNATNVVIK (13aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- GWIFGTTLDSKTQSLLIVNNATNVVIK (27aa)
- KTQSLLIVNNATNVVIK (17aa)
- AASTYSIDSVSFSYNTGDNTTFPDAEDK (28aa)
- IVDHGNGTFSVHFR (14aa)
- FGCEIENNR (9aa)
- LQAQDSGFYECYTPSTDTQYLGNYSAK (27aa)
- ARGNGTLITFHSAFQCCGK (19aa)
- GTFTDCALANMTEQIR (16aa)
- GFYCSWHLPTPTYIPNTFNVTVLHGSK (27aa)
- IVDHGNGTFSVYFR (14aa)
- YHKNNKSWMESEF (13aa)
- VCEFQFCNDPFLGVYYHKNNK (21aa)
- LNFGVGNNSEAVISQFYHSPADNKR (25aa)
- VYMKNVTVVLR (11aa)
- SSANNCTFEYVSQPF (15aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- NQSVPISCCR (10aa)
- FGYILHTDNR (10aa)
- AFSNSSYVINPTTGEIVFDPISASDTGEYSCEAR (34aa)
- QIGLYPVLVIDSSGYVNPNYTGR (23aa)
- DGKPLLNDSR (10aa)
- KNASNMEYR (9aa)
- NGVELTATRKNASNMEYR (18aa)
- NASNMEYR (8aa)
- LKGEAEYQEIRNPNGTVTVISR (22aa)
- NLFLNHSENAT (11aa)
- NLFLNHSENAT (11aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- FNHTQTIQQK (10aa)
- EPFYKNSTFGSVEVFSLDPNKVHK (24aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLALH (31aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLAL (30aa)
- PIGINITRFQTLLALHR (17aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYL (56aa)
- HTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLL (36aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDS (40aa)
- LVDLPIGINITRFQTLLALHR (21aa)
- SALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPR (53aa)
- WSCDHKQNITYLLK (14aa)
- GINIT (5aa)
- LPIGINITR (9aa)
- LPQGFSALEPLVDLPIGINITR (22aa)
- PLVDLPIGINITR (13aa)
- LPIGINITRFQTLLALHR (18aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- EIGVVMYNCSCIAR (14aa)
- HMNETSHTQGSLR (13aa)
- LLFPTNSSSR (10aa)
- KDNTTVTR (8aa)
- YQYVDCGRNTT (11aa)
- TVIENSTSYEEAK (13aa)
- IININPNK (8aa)
- SPHRPILQAGLPANK (15aa)
- MIENGSISFIPTIR (14aa)
- THTNISESHPNATFSAVGEASICEDDWNSGER (32aa)
- IMESHPNGTFSAK (13aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- NGTITDAVDCALDPLSE (17aa)
- IIAPAYFIIGGNQSGEGCVITR (22aa)
- HYGNYTCR (8aa)
- IIDGDITSDPSYFQNVTGCSNYYNFIR (27aa)
- FFHVNGSAFLPR (12aa)
- EDGMLPANR (9aa)
- IIQVVYIHSNNITK (14aa)
- VLKDAVNNITAK (12aa)
- RIGPGEPLELLCNVSGALPPPGR (23aa)
- IGPGEPLELLCNVSGALPPPGR (22aa)
- FFAENETWVVDSCTTCTCK (19aa)
- VQPTESIVRFPNITNLCPFGEVFNATRFASVY (32aa)
- RFPNIT (6aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- FPNITNLCPFGE (12aa)
- DQSEDDRQHECLNVTQLLK (19aa)
- GEVFNATRF (9aa)
- VQPFNVTQGK (10aa)
- KVSCPIMPCSNATVPDGECCPR (22aa)
- QIVINITGNTICAGGASDEK (20aa)
- SINTTNVMGTSLTVR (15aa)
- ATQLFTNQTDIPNMEDVYAVK (21aa)
- IFNIHSGNGSLYTSKPLDR (19aa)
- ANQTALCGGGVQTR (14aa)
- INFTAPFNPNK (11aa)
- RANQTALCGGGVQTR (15aa)
- ALYAWNNGHQTLYNVTLFHVIR (22aa)
- FFPYANGTLSIR (12aa)
- IIISPEENVTLTCTAENQLER (21aa)
- YQGICPPVARNETHFDAGAK (20aa)
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
- GTNESEASSTQFTTEIDAPK (20aa)
- NLSVVILGASDKDLHPNTDPFKFEIHK (27aa)
- EVNDTLLVNELK (12aa)
- GGVSVITPGTNTSNQVAVLY (20aa)
- VITPGTNTS (9aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- LYQDVNCT (8aa)
- TLNCSGAHVK (10aa)
- ISKINNTHALVSLLQNLNK (19aa)
- AGCLIGAEHVNNSYECDIPIG (21aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYE (15aa)
- SIVVEWTNNTLPLEPCPK (18aa)
- TAPKNVSDIIPR (12aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILP (38aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTEILPVSMTK (31aa)
- NSIAIPTNFTISVTTEILPVSMTK (24aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQL (73aa)
- NFTIS (5aa)
- KVEVEPLNSTAVHVSWK (17aa)
- VFLNGTHR (8aa)
- CACGIERNCTDPK (13aa)
- LSHDGNETLPLHLYVK (16aa)
- NLTLK (5aa)
- FHINK (5aa)
- DFGGFNFSQILPDPSKPSKRSFIEDLLFNK (30aa)
- PPIKDFGGFNF (11aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- NVTAQICIDK (10aa)
- YVPFNGTK (8aa)
- QMVENFSPNQTK (12aa)
- THNLTNLNPDLQYR (14aa)
- HNFRPGTDFVVEYIDSNHTKK (21aa)
- HNFRPGTDFVVEYIDSNHTK (20aa)
- VVNSTTGPGEHIR (13aa)
- VPAQEKNF (8aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- KNFTTAPAICHDGK (14aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- NGTHWFV (7aa)
- NGTHWFVT (8aa)
- GVFVSNGTHWFVTQR (15aa)
- EGVFVSNGTHWFVTQRNFYEPQ (22aa)
- EGVFVSNGTHWFVTQRNFY (19aa)
- TNGTGPVR (8aa)
- VLLHHLDVKTNGTGPVR (17aa)
- NHTSPDVDLGDISGIN (16aa)
- NH (2aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- SGINASVVNIQK (12aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIML (43aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMT (47aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVT (40aa)
- NLNESLIDLQELGKYEQYIK (20aa)
- IGSYNGTAGDSLSYHQGRPFSTEDRDNDVAVTNCAMSYK (39aa)
- LPNNMNQTK (9aa)
- VLNMAAENNPNIKINGSVR (19aa)
- WTGHNVTVVQR (11aa)
- GPCSHLCLINHNR (13aa)
- LHKDNTTCYEFKK (13aa)
- ITLHENR (7aa)
- ITVHGNGSLDIR (12aa)
- MIEAYNITEK (10aa)
- EAGNITTDGYEIIGK (15aa)
- VSIIDNGTITVR (12aa)
- LTSCATNASMCGDEAR (16aa)
- FGTCSQICNNTK (12aa)
- FGTCSQLCNNTK (12aa)
- GVTHLNISGLK (11aa)
- FGHSPLINLTGGLSHASDVVLYHQHK (26aa)
- VVLLDPKPVANVTCVNK (17aa)
Mass spectrometry observed peptide
-
- Free / Lactose (avg mass : 1584.4553)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1584.4553)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1584.4553)
- Milk (UBERON_0001913)
- Creating a Mass Spectral Reference Library for Oligosaccharides in Human Milk (2018 - Connie A Remoroza, Tytus D Mak, Maria Lorna A De Leoz, Yuri A Mirokhin, Stephen E Stein) / Status : Unreviewed
- Development of an Annotated Library of Neutral Human Milk Oligosaccharides (2010 - Shuai Wu, Nannan Tao, J Bruce German, Rudolf Grimm, Carlito B Lebrilla) / Status : Unreviewed
-
- Free / Lactose (avg mass : 1584.4553)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1584.4553)
- Milk (UBERON_0001913)
- Creating a Mass Spectral Reference Library for Oligosaccharides in Human Milk (2018 - Connie A Remoroza, Tytus D Mak, Maria Lorna A De Leoz, Yuri A Mirokhin, Stephen E Stein) / Status : Unreviewed
- Annotation and Structural Analysis of Sialylated Human Milk Oligosaccharides (2011 - Shuai Wu, Rudolf Grimm, J Bruce German, Carlito B Lebrilla) / Status : Unreviewed
- Development of an Annotated Library of Neutral Human Milk Oligosaccharides (2010 - Shuai Wu, Nannan Tao, J Bruce German, Rudolf Grimm, Carlito B Lebrilla) / Status : Unreviewed
-
- Free / Lactose (avg mass : 1584.4553)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1584.4553)
- Milk (UBERON_0001913)
-
- N-Linked / Complex (avg mass : 1584.4553)
- Seminal Fluid (UBERON_0006530)
- Major seminal plasma glycoprotein psp-i / Sus scrofa
- Major seminal plasma glycoprotein psp-ii / Sus scrofa
-
- N-Linked / Hybrid (avg mass : 1584.4553)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
- Comparative study of the sugar chains of alkaline phosphatases purified from rat liver and rat AH-130 hepatoma cells. Occurrence of fucosylated high-mannose-type and hybrid-type sugar chains. (1996 - Endo T, Fujiwara T, Ikehara Y, Kobata A) / Status : Reviewed
- Oligosaccharides at individual glycosylation sites in glycoprotein 71 of Friend murine leukemia virus. (1990 - Geyer R, Dabrowski J, Dabrowski U, Linder D, Schlter M, Schott H, Stirm S) / Status : Reviewed
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
- Knob protein gp70 / Friend murine leukemia virus
-
- N-Linked / Hybrid (avg mass : 1584.4553)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Salivary plasminogen activator alpha 1 / Desmodus rotundus
-
- N-Linked / Hybrid (avg mass : 1584.4553)
- Blood Serum (UBERON_0001977)
-
Acetylcholinesterase / Bos taurus
- Undefined site
-
- N-Linked / Hybrid (avg mass : 1584.4553)
- Retina (UBERON_0000966)
-
Rhodopsin / Homo sapiens
- Undefined site
-
- Hex:5 HexNAc:3 dHex:1 / N-Linked (avg mass : 1584.4553)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Mammary Gland (UBERON_0001911)
- BTI-Tn-5B1-4 (CVCL_C190)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Hybrid / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-3)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Hybrid / Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Man(a1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Hybrid / Man(?1-?)[Man(?1-?)]Man(a1-?)[GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
- N-Linked / Hybrid / Man(a1-3)[Man(a1-6)]Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Site-specific analysis of the SARS-CoV-2 glycan shield (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Unreviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- A disintegrin and metalloproteinase with thrombospondin motifs 12 / Homo sapiens
- Acid ceramidase / Homo sapiens
- Alpha-2-macroglobulin / Homo sapiens
- Apolipoprotein d / Homo sapiens
- Biglycan / Homo sapiens
- Collagen alpha-1(VI) chain / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-2(VI) chain / Homo sapiens
- Decorin / Homo sapiens
- Dystroglycan / Homo sapiens
- Fibronectin / Homo sapiens
- Haptoglobin / Homo sapiens
- Heterogeneous nuclear ribonucleoprotein A/B isoform 2 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Integrin alpha-V / Homo sapiens
- Interleukin-1 receptor accessory protein / Homo sapiens
- Junctional adhesion molecule A / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Mannan-binding lectin serine protease 1 / Homo sapiens
- Matrix-remodeling-associated protein 5 / Homo sapiens
- Mucin-5B / Homo sapiens
- Myelin protein P0 / Homo sapiens
- Myelin protein zero-like protein 1 / Homo sapiens
- Periostin / Homo sapiens
- Phospholipase D3 / Homo sapiens
- Podocalyxin / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Probable serine carboxypeptidase CPVL / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Recombinant mature angiotensin-converting enzyme 2 - DRAFT DATA / Homo sapiens
- Serpin h1 / Homo sapiens
- Tetraspanin-3 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Thrombospondin-2 / Homo sapiens
- Thyroglobulin / Homo sapiens
- Transmembrane protein 106B / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 / Mus musculus
- Angiotensin-converting enzyme / Mus musculus
- BDNF/NT-3 growth factors receptor / Mus musculus
- BTB/POZ domain-containing protein 17 / Mus musculus
- Cadherin-10 / Mus musculus
- Cadherin-13 / Mus musculus
- Carboxypeptidase M / Mus musculus
- Cation-dependent mannose-6-phosphate receptor / Mus musculus
- CD166 antigen / Mus musculus
- Cell adhesion molecule 4 / Mus musculus
- Ciliary neurotrophic factor receptor subunit alpha / Mus musculus
- Contactin-3 / Mus musculus
- Contactin-associated protein-like 2 / Mus musculus
- Dipeptidyl aminopeptidase-like protein 6 / Mus musculus
- Ephrin-A1 / Mus musculus
- Fibroblast growth factor receptor 1 / Mus musculus
- Hepatocyte cell adhesion molecule / Mus musculus
- IgLON family member 5 / Mus musculus
- Immunoglobulin mu chain C region / Mus musculus
- Immunoglobulin superfamily member 8 / Mus musculus
- Isoform 14 of Disintegrin and metalloproteinase domain-containing protein 22 / Mus musculus
- Isoform 2D of Voltage-dependent calcium channel subunit alpha-2/delta-1 / Mus musculus
- Leucine-rich glioma-inactivated protein 1 / Mus musculus
- Leukocyte surface antigen CD47 / Mus musculus
- Low-density lipoprotein receptor-related protein 1B / Mus musculus
- Lysosomal acid phosphatase / Mus musculus
- Lysosome-associated membrane glycoprotein 1 / Mus musculus
- Metabotropic glutamate receptor 3 / Mus musculus
- Myelin-oligodendrocyte glycoprotein / Mus musculus
- Nectin-1 / Mus musculus
- Neural cell adhesion molecule L1 / Mus musculus
- Neurexin-3 / Mus musculus
- Neurexophilin-1 / Mus musculus
- Neurexophilin-3 / Mus musculus
- Neurofascin / Mus musculus
- Neuronal cell adhesion molecule / Mus musculus
- Neuroplastin / Mus musculus
- Noelin / Mus musculus
- Oligodendrocyte-myelin glycoprotein / Mus musculus
- Plexin-B1 / Mus musculus
- Plexin-B2 / Mus musculus
- Prolow-density lipoprotein receptor-related protein 1 / Mus musculus
- Prostaglandin-H2 D-isomerase / Mus musculus
- Receptor-type tyrosine-protein phosphatase F / Mus musculus
- Rho-associated protein kinase 2 / Mus musculus
- Roundabout homolog 2 / Mus musculus
- Signal-regulatory protein alpha / Mus musculus
- Sortilin-related receptor / Mus musculus
- Synaptophysin-like protein 1 / Mus musculus
- Tenascin-r / Mus musculus
- Tetraspanin-2 / Mus musculus
- Thrombospondin type-1 domain-containing protein 7A / Mus musculus
- Thy-1 membrane glycoprotein / Mus musculus
- Zinc transporter ZIP10 / Mus musculus
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- QCVNLTTR (8aa)
- VLLPLVSSQCVNLTTRTQLPPAYTNSFTR (29aa)
- HIVFWNSSNPK (11aa)
- SPLPAAFTANGTHLQHLAR (19aa)
- SVAQNYSSITHLHSIGK (17aa)
- EIFVANGTQGK (11aa)
- WYSAGLASNSSWFR (14aa)
- YETTNK (6aa)
- LRPLFNK (7aa)
- ISPGKNATGMEVGWYR (16aa)
- NATGMEVGWYR (11aa)
- FSNVTWF (7aa)
- GESPAGAGTGAAAGAGGATAAPPSGNQNGAEGDQINASK (39aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- WKLNK (5aa)
- WQLNGSDIDTSLDHR (15aa)
- QTLFFNGTR (9aa)
- VGVNKNQTVTATFGYPFR (18aa)
- ANTTQPGIVEGGQVIK (16aa)
- VTWFHAIHVSGTNGTKR (17aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- PLQEIQNL (8aa)
- IRNVSDTTK (9aa)
- IRNVSDTTKR (10aa)
- YHGFLNTSYHR (11aa)
- VLTLANFTTK (10aa)
- ADGTVNQIEGEATPVNITEPAKIEVK (26aa)
- DAMVGNYTCEVTELSR (16aa)
- ISNVTPADAGIYYCVK (16aa)
- NVETNNSTVLIEGK (14aa)
- DEGDYFCELQVSGANPMSSNK (21aa)
- NTTYCSK (7aa)
- IIRGWIFGTTLDSKTQSLLIVNNATNVVIK (30aa)
- DGSIVIHNLDYSDNGTFTCDVK (22aa)
- TQSLLIVNNATNVVIKVCEFQFCNDPFL (28aa)
- SLLIVNNATNVVIK (14aa)
- TTLDSKTQSLLIVNNATNVVIK (22aa)
- LIVNNATNVVIK (12aa)
- DSKTQSLLIVNNATNVVIK (19aa)
- LLIVNNATNVVIK (13aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- GWIFGTTLDSKTQSLLIVNNATNVVIK (27aa)
- KTQSLLIVNNATNVVIK (17aa)
- AASTYSIDSVSFSYNTGDNTTFPDAEDK (28aa)
- IVDHGNGTFSVHFR (14aa)
- FGCEIENNR (9aa)
- LQAQDSGFYECYTPSTDTQYLGNYSAK (27aa)
- ARGNGTLITFHSAFQCCGK (19aa)
- GTFTDCALANMTEQIR (16aa)
- GFYCSWHLPTPTYIPNTFNVTVLHGSK (27aa)
- IVDHGNGTFSVYFR (14aa)
- YHKNNKSWMESEF (13aa)
- VCEFQFCNDPFLGVYYHKNNK (21aa)
- LNFGVGNNSEAVISQFYHSPADNKR (25aa)
- VYMKNVTVVLR (11aa)
- SSANNCTFEYVSQPF (15aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- NQSVPISCCR (10aa)
- FGYILHTDNR (10aa)
- AFSNSSYVINPTTGEIVFDPISASDTGEYSCEAR (34aa)
- QIGLYPVLVIDSSGYVNPNYTGR (23aa)
- DGKPLLNDSR (10aa)
- KNASNMEYR (9aa)
- NGVELTATRKNASNMEYR (18aa)
- NASNMEYR (8aa)
- LKGEAEYQEIRNPNGTVTVISR (22aa)
- NLFLNHSENAT (11aa)
- NLFLNHSENAT (11aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- FNHTQTIQQK (10aa)
- EPFYKNSTFGSVEVFSLDPNKVHK (24aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLALH (31aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLAL (30aa)
- PIGINITRFQTLLALHR (17aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYL (56aa)
- HTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLL (36aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDS (40aa)
- LVDLPIGINITRFQTLLALHR (21aa)
- SALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPR (53aa)
- WSCDHKQNITYLLK (14aa)
- GINIT (5aa)
- LPIGINITR (9aa)
- LPQGFSALEPLVDLPIGINITR (22aa)
- PLVDLPIGINITR (13aa)
- LPIGINITRFQTLLALHR (18aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- EIGVVMYNCSCIAR (14aa)
- HMNETSHTQGSLR (13aa)
- LLFPTNSSSR (10aa)
- KDNTTVTR (8aa)
- YQYVDCGRNTT (11aa)
- TVIENSTSYEEAK (13aa)
- IININPNK (8aa)
- SPHRPILQAGLPANK (15aa)
- MIENGSISFIPTIR (14aa)
- THTNISESHPNATFSAVGEASICEDDWNSGER (32aa)
- IMESHPNGTFSAK (13aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- NGTITDAVDCALDPLSE (17aa)
- IIAPAYFIIGGNQSGEGCVITR (22aa)
- HYGNYTCR (8aa)
- IIDGDITSDPSYFQNVTGCSNYYNFIR (27aa)
- FFHVNGSAFLPR (12aa)
- EDGMLPANR (9aa)
- IIQVVYIHSNNITK (14aa)
- VLKDAVNNITAK (12aa)
- RIGPGEPLELLCNVSGALPPPGR (23aa)
- IGPGEPLELLCNVSGALPPPGR (22aa)
- FFAENETWVVDSCTTCTCK (19aa)
- VQPTESIVRFPNITNLCPFGEVFNATRFASVY (32aa)
- RFPNIT (6aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- FPNITNLCPFGE (12aa)
- DQSEDDRQHECLNVTQLLK (19aa)
- GEVFNATRF (9aa)
- VQPFNVTQGK (10aa)
- KVSCPIMPCSNATVPDGECCPR (22aa)
- QIVINITGNTICAGGASDEK (20aa)
- SINTTNVMGTSLTVR (15aa)
- ATQLFTNQTDIPNMEDVYAVK (21aa)
- IFNIHSGNGSLYTSKPLDR (19aa)
- ANQTALCGGGVQTR (14aa)
- INFTAPFNPNK (11aa)
- RANQTALCGGGVQTR (15aa)
- ALYAWNNGHQTLYNVTLFHVIR (22aa)
- FFPYANGTLSIR (12aa)
- IIISPEENVTLTCTAENQLER (21aa)
- YQGICPPVARNETHFDAGAK (20aa)
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
- GTNESEASSTQFTTEIDAPK (20aa)
- NLSVVILGASDKDLHPNTDPFKFEIHK (27aa)
- EVNDTLLVNELK (12aa)
- GGVSVITPGTNTSNQVAVLY (20aa)
- VITPGTNTS (9aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- LYQDVNCT (8aa)
- TLNCSGAHVK (10aa)
- ISKINNTHALVSLLQNLNK (19aa)
- AGCLIGAEHVNNSYECDIPIG (21aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYE (15aa)
- SIVVEWTNNTLPLEPCPK (18aa)
- TAPKNVSDIIPR (12aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILP (38aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTEILPVSMTK (31aa)
- NSIAIPTNFTISVTTEILPVSMTK (24aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQL (73aa)
- NFTIS (5aa)
- KVEVEPLNSTAVHVSWK (17aa)
- VFLNGTHR (8aa)
- CACGIERNCTDPK (13aa)
- LSHDGNETLPLHLYVK (16aa)
- NLTLK (5aa)
- FHINK (5aa)
- DFGGFNFSQILPDPSKPSKRSFIEDLLFNK (30aa)
- PPIKDFGGFNF (11aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- NVTAQICIDK (10aa)
- YVPFNGTK (8aa)
- QMVENFSPNQTK (12aa)
- THNLTNLNPDLQYR (14aa)
- HNFRPGTDFVVEYIDSNHTKK (21aa)
- HNFRPGTDFVVEYIDSNHTK (20aa)
- VVNSTTGPGEHIR (13aa)
- VPAQEKNF (8aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- KNFTTAPAICHDGK (14aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- NGTHWFV (7aa)
- NGTHWFVT (8aa)
- GVFVSNGTHWFVTQR (15aa)
- EGVFVSNGTHWFVTQRNFYEPQ (22aa)
- EGVFVSNGTHWFVTQRNFY (19aa)
- TNGTGPVR (8aa)
- VLLHHLDVKTNGTGPVR (17aa)
- NHTSPDVDLGDISGIN (16aa)
- NH (2aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- SGINASVVNIQK (12aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIML (43aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMT (47aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVT (40aa)
- NLNESLIDLQELGKYEQYIK (20aa)
- IGSYNGTAGDSLSYHQGRPFSTEDRDNDVAVTNCAMSYK (39aa)
- LPNNMNQTK (9aa)
- VLNMAAENNPNIKINGSVR (19aa)
- WTGHNVTVVQR (11aa)
- GPCSHLCLINHNR (13aa)
- LHKDNTTCYEFKK (13aa)
- ITLHENR (7aa)
- ITVHGNGSLDIR (12aa)
- MIEAYNITEK (10aa)
- EAGNITTDGYEIIGK (15aa)
- VSIIDNGTITVR (12aa)
- LTSCATNASMCGDEAR (16aa)
- FGTCSQICNNTK (12aa)
- FGTCSQLCNNTK (12aa)
- GVTHLNISGLK (11aa)
- FGHSPLINLTGGLSHASDVVLYHQHK (26aa)
- VVLLDPKPVANVTCVNK (17aa)
Source
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reference
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reference
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reference
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
